Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis
Parenteral methotrexate was not superior to placebo in preventing relapses of UC in patients who achieved steroid-free response during induction therapy. At week 48, 30% of patients in the placebo group (12/40) and 27% of those in the methotrexate group were in steroid-free clinical remission without the need for additional therapies.

Related Post